A discussion about the effectiveness of new cancer drugs and the impact of their high price on patients and doctors.

Guests

  • Randy Burkholder Associate Vice President of Policy, Pharmaceutical Research and Manufacturers of America
  • Dr. Ed Pezalla National Medical Director for Aetna Pharmacy Management, Hartford CT.
  • Kevin LaMartina Patient Resource Navigator, The American Cancer Society, at St. Agnes Hospital, Baltimore, MD.
  • Dr. Neal Meropol Director, Gastrointestinal Cancer Program, Fox Chase Cancer Center, Philadelphia, PA
  • Dr. John Marshall Chief, Division of Hematology/Oncology at Georgetown's Lombardi Comprehensive Cancer Center, Washington, D.C.

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

New York Times Columnist David Brooks

Friday, Feb 24 2017New York Times columnist David Brooks talks with Diane about what he sees happening inside Washington and around the country and why he thinks President Trump represents the wrong answer to the right question.

Efforts to Improve The Way We Die

Friday, Feb 17 2017Diane speaks with Dr. Roger Kligler who is living with advanced stage cancer on why he's suing the state of Massachusetts for the 'Right to Die' and with Dr. Jessica Zitter, and intensive care and palliative care specialist on why better communication is so needed between doctors and patients facing end-of-life issues.

Two Weeks In: The U.S. Government Under President Trump

Friday, Feb 03 2017President Trump announces his nominee for the Supreme Court, legal battles ramp up in opposition to the Trump's executive order on immigration restrictions,and some in Congress vow to resist: Three political experts speculate on the future of our three branches of government and their respective powers in the Trump administration.